Logo image of JTAI

JET.AI INC (JTAI) Stock Fundamental Analysis

USA - NASDAQ:JTAI - US47714H3084 - Common Stock

3.15 USD
-0.1 (-3.07%)
Last: 9/17/2025, 8:00:02 PM
3.2 USD
+0.05 (+1.59%)
Pre-Market: 9/18/2025, 6:30:03 AM
Fundamental Rating

0

Overall JTAI gets a fundamental rating of 0 out of 10. We evaluated JTAI against 21 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JTAI have multiple concerns. JTAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

JTAI had negative earnings in the past year.
JTAI had a negative operating cash flow in the past year.
JTAI Yearly Net Income VS EBIT VS OCF VS FCFJTAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -335.49%, JTAI is doing worse than 95.24% of the companies in the same industry.
Industry RankSector Rank
ROA -335.49%
ROE N/A
ROIC N/A
ROA(3y)-56.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JTAI Yearly ROA, ROE, ROICJTAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for JTAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JTAI Yearly Profit, Operating, Gross MarginsJTAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

JTAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
JTAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JTAI Yearly Shares OutstandingJTAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
JTAI Yearly Total Debt VS Total AssetsJTAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -23.10, we must say that JTAI is in the distress zone and has some risk of bankruptcy.
JTAI's Altman-Z score of -23.10 is on the low side compared to the rest of the industry. JTAI is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.1
ROIC/WACCN/A
WACC9.26%
JTAI Yearly LT Debt VS Equity VS FCFJTAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

JTAI has a Current Ratio of 0.33. This is a bad value and indicates that JTAI is not financially healthy enough and could expect problems in meeting its short term obligations.
JTAI has a worse Current ratio (0.33) than 85.71% of its industry peers.
A Quick Ratio of 0.33 indicates that JTAI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.33, JTAI is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
JTAI Yearly Current Assets VS Current LiabilitesJTAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.82%

3.2 Future

JTAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.86% yearly.
The Revenue is expected to decrease by -45.63% on average over the next years. This is quite bad
EPS Next Y97.13%
EPS Next 2Y40.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-39.51%
Revenue Next 2Y-45.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

JTAI Yearly Revenue VS EstimatesJTAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M
JTAI Yearly EPS VS EstimatesJTAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

JTAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JTAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JTAI Price Earnings VS Forward Price EarningsJTAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JTAI Per share dataJTAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40 -50

4.3 Compensation for Growth

A more expensive valuation may be justified as JTAI's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JTAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JET.AI INC

NASDAQ:JTAI (9/17/2025, 8:00:02 PM)

Premarket: 3.2 +0.05 (+1.59%)

3.15

-0.1 (-3.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-14 2025-11-14/bmo
Inst Owners3.78%
Inst Owner Change-14.95%
Ins Owners1.23%
Ins Owner Change0%
Market Cap10.27M
Analysts82.86
Price Target11.22 (256.19%)
Short Float %4.52%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.61%
Min EPS beat(2)-11.41%
Max EPS beat(2)-9.8%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.7%
Min Revenue beat(2)-5.78%
Max Revenue beat(2)9.18%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-45%
PT rev (3m)-45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-50.4
EYN/A
EPS(NY)-2.66
Fwd EYN/A
FCF(TTM)-2.03
FCFYN/A
OCF(TTM)-2.02
OCFYN/A
SpS4.44
BVpS-1.28
TBVpS-1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -335.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-56.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover3.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.84%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -23.1
F-Score3
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.36%
EPS Next Y97.13%
EPS Next 2Y40.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.82%
Revenue Next Year-39.51%
Revenue Next 2Y-45.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-332.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.81%
EBIT Next 3Y20.75%
EBIT Next 5YN/A
FCF growth 1Y-46172.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45841.8%
OCF growth 3YN/A
OCF growth 5YN/A